FDA approves first medication to reduce allergic reactions
Drug Discovery World
FEBRUARY 26, 2024
The US Food and Drug Administration (FDA) has approved monoclonal antibody Xolair (omalizumab) for immunoglobulin E-mediated food allergy in some adults and children one year or older for the reduction of allergic reactions (Type I).
Let's personalize your content